Health And Medicine

Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19. Read More

Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%. Read More

Ege T. Kavalali, William Stokes Professor of Experimental Therapeutics, has been named chair of the Department of Pharmacology in the Vanderbilt University School of Medicine Basic Sciences. Read More

Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure. Read More

Vanderbilt researchers test and recommend statistical approaches to study the association between engagement with digital health interventions and clinical outcomes. Read More

Vanderbilt researchers help answer the question of why patients with autoimmune diseases like lupus are more susceptible to bacterial infections: their neutrophils have impaired antibacterial activity. Read More

Provost and Vice Chancellor for Academic Affairs C. Cybele Raver joins six others at Vanderbilt as 2021 fellows of the American Association for the Advancement of Science, the world’s largest general scientific society. Read More

When Joseph Sexton’s friend died by suicide in high school, Sexton channeled his grief into a research quest to better understand depressive behaviors.  The Georgia native started studying the systems and molecular neuroscience behind mood. By his senior year of high school, he was doing research at Georgia… Read More

A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States. Read More

By Aaron Conley Systems biology and the Lopez lab The history of hermeneutics started with Aristotle—parts comprise the whole. To understand the whole, we need to understand the parts. And to understand the parts, we need to understand them in the context of the whole. Carlos F. Lopez, associate… Read More

Join taste experts, scientists and a Nashville chef to learn about the science behind flavor in a virtual event on Monday, Jan. 31, at noon CT. Read More

A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors. Read More

Dr. William Schaffner, an internationally renowned infectious disease specialist and public health expert, shares what you should know about the latest COVID-19 variant wave, including information about breakthrough symptoms for the vaccinated population. Read More

A team of Vanderbilt researchers led by Ken Lau has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Read More

Lars Plate wins $55,000 from Scialog to further collaborative research on cell behavior. Read More

Vanderbilt researchers have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs. Read More

New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Read More

Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. Read More

There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stoke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. Read More

Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time. Read More